- Home
- RVPH vs AIRI Comparison
RVPH vs AIRI Comparison
Compare RVPH & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- AIRI
- Stock Information
- Founded
- RVPH 2006
- AIRI 1979
- Country
- RVPH United States
- AIRI United States
- Employees
- RVPH N/A
- AIRI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- AIRI Military/Government/Technical
- Sector
- RVPH Health Care
- AIRI Industrials
- Exchange
- RVPH Nasdaq
- AIRI Nasdaq
- Market Cap
- RVPH 18.1M
- AIRI 15.2M
- IPO Year
- RVPH N/A
- AIRI N/A
- Fundamental
- Price
- RVPH $0.57
- AIRI $3.32
- Analyst Decision
- RVPH Strong Buy
- AIRI
- Analyst Count
- RVPH 6
- AIRI 0
- Target Price
- RVPH $4.50
- AIRI N/A
- AVG Volume (30 Days)
- RVPH 19.3M
- AIRI 45.3K
- Earning Date
- RVPH 11-13-2025
- AIRI 11-13-2025
- Dividend Yield
- RVPH N/A
- AIRI N/A
- EPS Growth
- RVPH N/A
- AIRI N/A
- EPS
- RVPH N/A
- AIRI N/A
- Revenue
- RVPH N/A
- AIRI $52,277,000.00
- Revenue This Year
- RVPH N/A
- AIRI N/A
- Revenue Next Year
- RVPH N/A
- AIRI $3.53
- P/E Ratio
- RVPH N/A
- AIRI N/A
- Revenue Growth
- RVPH N/A
- AIRI N/A
- 52 Week Low
- RVPH $0.25
- AIRI $2.80
- 52 Week High
- RVPH $4.28
- AIRI $6.28
- Technical
- Relative Strength Index (RSI)
- RVPH 52.50
- AIRI 58.03
- Support Level
- RVPH $0.42
- AIRI $3.14
- Resistance Level
- RVPH $0.69
- AIRI $3.25
- Average True Range (ATR)
- RVPH 0.11
- AIRI 0.12
- MACD
- RVPH -0.02
- AIRI 0.01
- Stochastic Oscillator
- RVPH 32.74
- AIRI 97.73
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.